DueNorth Biodevelopment is a biotechnology company developing cancer biomarkers.
DueNorth BioDevelopment is a biotechnology company specializing in cancer biomarkers. Biomarkers are a critical step to defeat cancer. We validate & develop the discovery to a commercial product. First opportunity, two biomarker tests identifying patients highly likely to respond to a chemotherapy drug called taxanes. 1.1 Billion in savings to healthcare and insurers and 3 years to market. Tailored treatment is the next medical revolution.